Kenan Aloss
Budapest, BU, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Sequencing PARP inhibitors in breast cancer: lessons learned and emerging insights.
Journal: NPJ breast cancer
Published: November 30, 2025
Expression of costimulatory molecule CD70 is prognostic in small cell lung cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: December 11, 2024
Ivermectin Synergizes with Modulated Electro-hyperthermia and Improves Its Anticancer Effects in a Triple-Negative Breast Cancer Mouse Model.
Journal: ACS pharmacology & translational science
Published: May 27, 2024
Correction to "Digoxin-Mediated Inhibition of Potential Hypoxia-Related Angiogenic Repair in Modulated Electro-Hyperthermia (mEHT)-Treated Murine Triple-Negative Breast Cancer Model".
Journal: ACS pharmacology & translational science
Published: February 19, 2024
Augmentation of the EPR effect by mild hyperthermia to improve nanoparticle delivery to the tumor.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: February 12, 2024
Modulated Electro-Hyperthermia Accelerates Tumor Delivery and Improves Anticancer Activity of Doxorubicin Encapsulated in Lyso-Thermosensitive Liposomes in 4T1-Tumor-Bearing Mice.
Journal: International journal of molecular sciences
Published: January 15, 2024
Digoxin-Mediated Inhibition of Potential Hypoxia-Related Angiogenic Repair in Modulated Electro-Hyperthermia (mEHT)-Treated Murine Triple-Negative Breast Cancer Model.
Journal: ACS pharmacology & translational science
Published: October 23, 2023
Heat shock factor 1 inhibition enhances the effects of modulated electro hyperthermia in a triple negative breast cancer mouse model.
Journal: Scientific reports
Published: October 20, 2023
Enhancing therapeutic efficacy in triple-negative breast cancer and melanoma: synergistic effects of modulated electro-hyperthermia (mEHT) with NSAIDs especially COX-2 inhibition in in vivo models.
Journal: Molecular oncology
Published: October 09, 2023
Recent Preclinical and Clinical Progress in Liposomal Doxorubicin.
Journal: Pharmaceutics
Published: February 16, 2023
Implication of the Gut Microbiome and Microbial-Derived Metabolites in Immune-Related Adverse Events: Emergence of Novel Biomarkers for Cancer Immunotherapy.
Journal: International journal of molecular sciences
Published: December 28, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026